BR0112682A - Método para reduzir exacerbações associadas com copd - Google Patents

Método para reduzir exacerbações associadas com copd

Info

Publication number
BR0112682A
BR0112682A BR0112682-2A BR0112682A BR0112682A BR 0112682 A BR0112682 A BR 0112682A BR 0112682 A BR0112682 A BR 0112682A BR 0112682 A BR0112682 A BR 0112682A
Authority
BR
Brazil
Prior art keywords
copd
exacerbations associated
reduce exacerbations
reduce
reducing
Prior art date
Application number
BR0112682-2A
Other languages
English (en)
Inventor
Jeffrey D Edelson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of BR0112682A publication Critical patent/BR0112682A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"MéTODO PARA REDUZIR EXACERBAçõES ASSOCIADAS COM COPD". Esta invenção refere-se a um método para reduzir as incidências e/ou a gravidade das exacerbações de COPD administrando-se um inibidor de fosfodiesterase 4 (PDE4).
BR0112682-2A 2000-07-27 2001-07-26 Método para reduzir exacerbações associadas com copd BR0112682A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22127500P 2000-07-27 2000-07-27
PCT/US2001/023542 WO2002009689A1 (en) 2000-07-27 2001-07-26 Method for reducing exacerbations associated with copd

Publications (1)

Publication Number Publication Date
BR0112682A true BR0112682A (pt) 2003-06-24

Family

ID=22827112

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112682-2A BR0112682A (pt) 2000-07-27 2001-07-26 Método para reduzir exacerbações associadas com copd

Country Status (16)

Country Link
EP (1) EP1320361A4 (pt)
JP (1) JP2004505039A (pt)
KR (1) KR20030019620A (pt)
CN (1) CN1444476A (pt)
AR (1) AR029984A1 (pt)
AU (2) AU7902301A (pt)
BR (1) BR0112682A (pt)
CA (1) CA2417336A1 (pt)
CZ (1) CZ2003141A3 (pt)
HU (1) HUP0300685A3 (pt)
IL (1) IL153919A0 (pt)
MX (1) MXPA03000714A (pt)
NO (1) NO20030332D0 (pt)
PL (1) PL365612A1 (pt)
WO (1) WO2002009689A1 (pt)
ZA (1) ZA200300476B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7776315B2 (en) 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
DE10110772A1 (de) * 2001-03-07 2002-09-12 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
DE10230769A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
KR102087661B1 (ko) * 2018-07-27 2020-03-11 강원대학교산학협력단 Ｇｅｂｒ―７ｂ 화합물을 유효성분으로 포함하는 만성폐쇄성 폐질환의 예방 또는 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ3019A1 (fr) * 1999-03-01 2005-05-20 Smithkline Beecham Corp Utilisation d'un inhibiteur de pde4 dans la préparation d'un médicament contre la copd.
SE9902937D0 (sv) * 1999-08-18 1999-08-18 Astra Pharma Prod Pharmaceutical compositions
DZ3249A1 (fr) * 1999-10-29 2001-05-10 Smithkline Beecham Corp Procédé d'administration d'un inhibiteur phosphodiesterase 4

Also Published As

Publication number Publication date
KR20030019620A (ko) 2003-03-06
AR029984A1 (es) 2003-07-23
CZ2003141A3 (cs) 2004-07-14
IL153919A0 (en) 2003-07-31
EP1320361A1 (en) 2003-06-25
AU7902301A (en) 2002-02-13
HUP0300685A3 (en) 2004-10-28
NO20030332L (no) 2003-01-22
AU2001279023B2 (en) 2005-11-10
HUP0300685A2 (hu) 2003-12-29
CA2417336A1 (en) 2002-02-07
NO20030332D0 (no) 2003-01-22
JP2004505039A (ja) 2004-02-19
MXPA03000714A (es) 2003-06-04
ZA200300476B (en) 2004-04-23
WO2002009689A1 (en) 2002-02-07
EP1320361A4 (en) 2006-04-05
CN1444476A (zh) 2003-09-24
PL365612A1 (en) 2005-01-10

Similar Documents

Publication Publication Date Title
MXPA02012712A (es) N-ureidoheterocicloalquil-piperidinas como moduladores de la actividad del receptor de quimiocinas.
ATE302606T1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
NO20012977L (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
WO2003029262A3 (en) The human mob-5 (il-24) receptors and uses thereof
BR0211274A (pt) Combinação de um antagonista de receptor de aldosterona e um inibidor de hmg co-a redutase
WO2003024401A3 (en) Piperizinones as modulators of chemokine receptor activity
BR0112682A (pt) Método para reduzir exacerbações associadas com copd
WO1999047131A3 (en) Combination of a gaba-a alpha 5 inverse agonist and an acetylcholinesterase inhibitor
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
AU2001245977A1 (en) Method and composition for preventing or reducing the symptoms of menopause
WO2003048207A3 (en) Anti-dota antibody
WO2004031105A3 (en) Use of a33 antigens and jam-it
ATE203519T1 (de) Chinolinderivate als antimalariamittel
WO2001098270A3 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BR9809848A (pt) Composição
BR9608594B1 (pt) misturas de benzimidazóis substituìdos para o combate de protozoários parasìticos.
DK0880964T3 (da) Aldosereduktaseinhibition til forebyggelse eller reversering af diabetisk cardiomyopati
TR200102448T2 (tr) COPD tedavisi için kontrollu salma formülasyonu.
WO2002051848A3 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
AP2001002248A0 (en) Method for treating COPD.
NO20001548D0 (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
AU2002320352A1 (en) Methods for treating or preventing sclerotic disorders using cd2-binding agents
DK1177191T3 (da) Substituerede benzimidazoler, fremstilling og anvendelse deraf som midler til bekæmpelse af parasitiske protozoer
WO2004112729A3 (en) Dual function compounds and uses thereof
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2021 DE 29/09/2009.